Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?

If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:

Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Premphase Side Effects Lawsuits | Side Effects: Dementia, Alzheimer's Disease, Strokes, Blood Clots, Pulmonary Embolisms, Lupus, Breast Cancer

Premphase Side Effects Could Lead To Breast Cancer Lawsuits

Premphase | Lawsuits, Lawyers | Side Effects: Dementia, Alzheimer's Disease, Strokes, Blood Clots, Pulmonary Embolisms, Lupus, Breast Cancer

Premphase (Generic: Conjugated estrogens and Medroxyprogesterone acetate) has been linked to the following side effects: dementia, Alzheimer's disease, stroke, blood clots, pulmonary embolisms, lupus and breast cancer. Premphase is a hormone replacement therapy (HRT) prescribed for menopause symptoms.

Approximately 6 million women are taking Prempro to treat post-menopausal hot flashes and other menopause symptoms. However, a recent major study concludes that long-term use of Prempro is dangerous and significantly increases the risk of stroke, blood clots, heart attacks and breast cancer. These results were discovered in the nation's biggest hormone replacement study and were so alarming that the National Institute of Health (NIH) prematurely canceled the study, citing risk to the study's participants. As a result, the study is suggesting that many of the women who use Prempro and other estrogen and progestin combinations should quit taking the medications and talk to their doctors about alternatives.

The evidence is clear that Prempro and other estrogen progestin combinations can harm perfectly healthy women. Women taking Prempro have a 29% higher risk of heart attack, 41% higher risk of stroke and a 26% higher risk of breast cancer. Another study released on May 27, 2003 about the health risks of hormone replacement therapy concluded that the medications can double the risk of dementia and Alzheimer's disease.

Premphase, Premarin and Prempro are manufactured by Wyeth and accounted for about $890 million of the company's $13.9 billion in sales in 2001.

Legal Help For Victims Affected By Premphase

If you or a loved one took Premphase and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us anytime at 1-800-YOURLAWYER (1-800-968-7529).


PremphaseRSS Feed

Pfizer Eyeing Prempro Lawsuit Settlements

May 17, 2011 | Parker Waichman LLP
It looks like Pfizer has had enough of the litigation surrounding its hormone therapy medication, Prempro.   According to a filing with the Securities and Exchange Commission (SEC), Pfizer disclosed it has set aside $772 million to settle hormone therapy lawsuits which it says is “the minimum expected costs to resolve all of the other outstanding” lawsuits.Pfizer inherited thousands of Prempro lawsuits when it acquired Wyeth in 2009, and at one time faced as many as...

Premarin, Prempro, Other Hormone Drugs Named in Nevada Lawsuit

Nov 20, 2008 | Parker Waichman LLP
Wyeth Pharmaceuticals is facing yet another lawsuit over its hormone replacement therapy drugs, Premarin, Prempro and Premphase.  This time, the state of Nevada is charging that Wyeth used deceptive practices in selling the drugs.  The Nevada attorney general has also targeted Pfizer, Inc.'s Provera.The Nevada lawsuit charges that Wyeth and Pfizer misled consumers about the safety and effectiveness of the hormone therapy drugs.  The lawsuit claims that the deception ...

Hormone Replacement Therapy – Even for Short Periods – Raises Breast Cancer Risk

Jan 16, 2008 | Parker Waichman LLP
U.S. researchers reported this week that hormone replacement therapy (HRT) significantly raises the risk of an uncommon type of breast cancer.  The study found women who took combined estrogen/progestin HRT for three years or more had four times the usual risk of lobular breast cancer.  The study, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, is one of dozens of studies looking to clarify the dangers of taking HRT to treat menopause symptoms. ...

Hormones can raise breast cancer risk

Apr 19, 2007 | AP
Research on two continents signaled more bad news for menopause hormones, offering the strongest evidence yet that they can raise the risk of breast cancer and are tied to a slightly higher risk of ovarian cancer. New U.S. government numbers showed that breast cancer rates leveled off in 2004 after plunging in 2003 the year after millions of women stopped taking hormones because a big study tied them to higher heart, stroke and breast cancer risks. Experts said the leveling off shows that the...

US drop in breast cancer linked to reduced hormone use

Apr 18, 2007 | AFP
A sharp decline in breast cancer rates in the United States in 2003 could be linked to a reduction in the use of hormone replacement therapy, according to research published Wednesday. The research, based on data from the National Cancer Institute, shows that the breast cancer incidence rates in women in the United States fell 6.7 percent in 2003 from the previous year and have since stabilized. The drop corresponds with a rapid decline in prescriptions for hormone replacement therapy (HRT)...

More Premphase News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo